US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.5550
  • -0.0550-3.42%
Trading May 17 14:26 ET
195.55MMarket Cap-6479P/E (TTM)

Atossa Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.66%6.98M
13.31%31.38M
10.83%9.02M
-8.98%7.47M
18.17%7.79M
49.53%7.1M
34.94%27.69M
68.56%8.14M
59.07%8.21M
-5.84%6.6M
Selling and administrative expenses
-9.97%3.23M
11.38%14.04M
6.76%3.37M
-1.44%3M
29.29%4.09M
10.53%3.59M
11.47%12.61M
5.03%3.15M
3.15%3.05M
-1.34%3.16M
-General and administrative expense
-9.97%3.23M
11.38%14.04M
6.76%3.37M
-1.44%3M
29.29%4.09M
10.53%3.59M
11.47%12.61M
5.03%3.15M
3.15%3.05M
-1.34%3.16M
Research and development costs
6.84%3.75M
14.92%17.33M
13.40%5.65M
-13.43%4.47M
7.92%3.71M
134.02%3.51M
63.77%15.08M
172.91%4.99M
133.91%5.16M
-9.63%3.43M
Operating profit
1.66%-6.98M
-13.31%-31.38M
-10.83%-9.02M
8.98%-7.47M
-18.17%-7.79M
-49.53%-7.1M
-34.94%-27.69M
-68.56%-8.14M
-59.07%-8.21M
5.84%-6.6M
Net non-operating interest income expense
33.88%1.14M
395.21%4.34M
84.48%1.24M
556.70%1.27M
8,836.36%983K
84,900.00%850K
14,516.67%877K
670K
194K
11K
Non-operating interest income
33.88%1.14M
395.21%4.34M
84.48%1.24M
556.70%1.27M
8,836.36%983K
84,900.00%850K
14,516.67%877K
--670K
--194K
--11K
Other net income (expense)
-9.09%-36K
-1,995.89%-3.06M
226.09%29K
-35K
-3,331.82%-3.02M
17.50%-33K
-60.44%-146K
-130.00%-23K
-151.43%-88K
Special income (charges)
----
---2.99M
--0
--0
---2.99M
----
--0
--0
--0
--0
-Write off
----
--2.99M
--0
--0
--2.99M
----
--0
--0
--0
--0
Other non- operating income (expenses)
-9.09%-36K
52.05%-70K
226.09%29K
---35K
65.91%-30K
17.50%-33K
-60.44%-146K
-130.00%-23K
----
-151.43%-88K
Income before tax
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.15%-8.01M
5.21%-6.67M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.15%-8.01M
5.21%-6.67M
Net income continuous Operations
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.15%-8.01M
5.21%-6.67M
Minority interest income
Net income attributable to the parent company
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.15%-8.01M
5.21%-6.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.15%-8.01M
5.21%-6.67M
Basic earnings per share
0.00%-0.05
-14.29%-0.24
0.00%-0.06
16.67%-0.05
-60.00%-0.08
-25.00%-0.05
-16.67%-0.21
-50.00%-0.06
-50.00%-0.06
16.67%-0.05
Diluted earnings per share
0.00%-0.05
-14.29%-0.24
0.00%-0.06
16.67%-0.05
-51.83%-0.08
-25.00%-0.05
-16.67%-0.21
-50.00%-0.06
-50.00%-0.06
12.18%-0.0527
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.66%6.98M13.31%31.38M10.83%9.02M-8.98%7.47M18.17%7.79M49.53%7.1M34.94%27.69M68.56%8.14M59.07%8.21M-5.84%6.6M
Selling and administrative expenses -9.97%3.23M11.38%14.04M6.76%3.37M-1.44%3M29.29%4.09M10.53%3.59M11.47%12.61M5.03%3.15M3.15%3.05M-1.34%3.16M
-General and administrative expense -9.97%3.23M11.38%14.04M6.76%3.37M-1.44%3M29.29%4.09M10.53%3.59M11.47%12.61M5.03%3.15M3.15%3.05M-1.34%3.16M
Research and development costs 6.84%3.75M14.92%17.33M13.40%5.65M-13.43%4.47M7.92%3.71M134.02%3.51M63.77%15.08M172.91%4.99M133.91%5.16M-9.63%3.43M
Operating profit 1.66%-6.98M-13.31%-31.38M-10.83%-9.02M8.98%-7.47M-18.17%-7.79M-49.53%-7.1M-34.94%-27.69M-68.56%-8.14M-59.07%-8.21M5.84%-6.6M
Net non-operating interest income expense 33.88%1.14M395.21%4.34M84.48%1.24M556.70%1.27M8,836.36%983K84,900.00%850K14,516.67%877K670K194K11K
Non-operating interest income 33.88%1.14M395.21%4.34M84.48%1.24M556.70%1.27M8,836.36%983K84,900.00%850K14,516.67%877K--670K--194K--11K
Other net income (expense) -9.09%-36K-1,995.89%-3.06M226.09%29K-35K-3,331.82%-3.02M17.50%-33K-60.44%-146K-130.00%-23K-151.43%-88K
Special income (charges) -------2.99M--0--0---2.99M------0--0--0--0
-Write off ------2.99M--0--0--2.99M------0--0--0--0
Other non- operating income (expenses) -9.09%-36K52.05%-70K226.09%29K---35K65.91%-30K17.50%-33K-60.44%-146K-130.00%-23K-----151.43%-88K
Income before tax 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.24%-6.23M-47.33%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.15%-8.01M5.21%-6.67M
Income tax 0000000000
Net income 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.24%-6.23M-47.33%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.15%-8.01M5.21%-6.67M
Net income continuous Operations 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.24%-6.23M-47.33%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.15%-8.01M5.21%-6.67M
Minority interest income
Net income attributable to the parent company 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.24%-6.23M-47.33%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.15%-8.01M5.21%-6.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.24%-6.23M-47.33%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.15%-8.01M5.21%-6.67M
Basic earnings per share 0.00%-0.05-14.29%-0.240.00%-0.0616.67%-0.05-60.00%-0.08-25.00%-0.05-16.67%-0.21-50.00%-0.06-50.00%-0.0616.67%-0.05
Diluted earnings per share 0.00%-0.05-14.29%-0.240.00%-0.0616.67%-0.05-51.83%-0.08-25.00%-0.05-16.67%-0.21-50.00%-0.06-50.00%-0.0612.18%-0.0527
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg